GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LungLife AI Inc (LSE:LLAI) » Definitions » Total Stockholders Equity

LungLife AI (LSE:LLAI) Total Stockholders Equity : £6.24 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is LungLife AI Total Stockholders Equity?

LungLife AI's Total Stockholders Equity for the quarter that ended in Jun. 2024 was £6.24 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. LungLife AI's Book Value per Share for the quarter that ended in Jun. 2024 was £0.20. The ratio of a company's debt over equity can be used to measure how leveraged this company is. LungLife AI's Debt-to-Equity for the quarter that ended in Jun. 2024 was 0.03.

LungLife AI Total Stockholders Equity Historical Data

The historical data trend for LungLife AI's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LungLife AI Total Stockholders Equity Chart

LungLife AI Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial -5.19 -8.41 15.14 10.79 6.25

LungLife AI Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 13.04 10.79 8.28 6.25 6.24

LungLife AI  (LSE:LLAI) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

LungLife AI's Book Value per Share for the quarter that ended in Jun. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(6.235-0)/30.6586
=0.20

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

LungLife AI's Debt-to-Equity for the quarter that ended in Jun. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.143 + 0.023) / 6.235
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LungLife AI Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of LungLife AI's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

LungLife AI Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LungLife AI Inc (LSE:LLAI) » Definitions » Total Stockholders Equity
Comparable Companies
LSE:PRM LSE:AGL LSE:ABDX LSE:VRCI LSE:GDR LSE:GENI LSE:DXRX TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH ILMN DGX WAT
Traded in Other Exchanges
N/A
Address
2545 W. Hillcrest Drive, Suite 140, Thousand Oaks, CA, USA, 91320
Website
https://www.lunglifeai.com
LungLife AI Inc is a diagnostic company focused on the early detection of lung cancer from a simple blood draw enhanced by artificial intelligence. Its LungLB Test is a blood-based tool developed to provide clinicians the information needed to make informed decisions about the management of lung nodules and lung cancer.

LungLife AI Headlines

No Headlines